{
    "clinical_study": {
        "@rank": "134536", 
        "acronym": "MAPPRO", 
        "arm_group": [
            {
                "arm_group_label": "Premature birth", 
                "arm_group_type": "Other", 
                "description": "At the end of the study patients will be divided into two groups: \"Premature delivery\" versus \"No premature delivery.\" Prematurity is defined as a birth before 37.\nIn each group, the procalcitonin rate be estimated with a confidence interval of 95% and compared from a logistic regression."
            }, 
            {
                "arm_group_label": "Not premature birth", 
                "arm_group_type": "Other", 
                "description": "At the end of the study patients will be divided into two groups: \"Premature delivery\" versus \"No premature delivery.\" Prematurity is defined as a birth before 37.\nIn each group, the procalcitonin rate be estimated with a confidence interval of 95% and compared from a logistic regression."
            }
        ], 
        "brief_summary": {
            "textblock": "Among all patients hospitalized for Threatened Premature Delivery (TPD), the rate of\n      premature birth (PB) before 37 weeks is about 42%, which reflects the inability to\n      accurately identify patients at high risk of PB. Currently, no clinical or biological marker\n      is recognized as the most reliable in predicting the real risk of AP in case of MAP.\n\n      The purpose of this study is to improve the knowledge of predictors of preterm delivery\n      compared with conventional blood markers by estimating serum procalcitonin according to\n      premature delivery or not in patients hospitalized for preterm labor ."
        }, 
        "brief_title": "Procalcitonin and Threatened Premature Delivery", 
        "completion_date": {
            "#text": "January 2016", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Pregnancy", 
            "Premature Delivery"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Obstetric Labor, Premature", 
                "Premature Birth"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  age > 18 year\n\n          -  Ongoing pregnancy with a start date of pregnancy known and confirmed by an ultrasound\n             of the 1st Quarter performed between 10 and 14 weeks with a measurement of the\n             crown-rump length\n\n          -  hospitalization for preterm labor between 24 and 36 weeks of gestation\n\n          -  Intact membranes,\n\n          -  not opposed to participate in the study\n\n        Exclusion Criteria:\n\n          -  Pregnancy uncertain term (no early ultrasound)\n\n          -  Pregnancy combining a condition that can interfere with the assays performed,\n\n          -  Uterine malformation known\n\n          -  Multiple pregnancy,\n\n          -  Premature rupture of membranes,\n\n          -  Chrorio-amnionitis,\n\n          -  Fetal malformation known\n\n          -  Strapping\n\n          -  GB> 15000 and CRP> 10 mg / L,\n\n          -  No affiliation to a social security scheme.\n\n          -  Woman with a measure of legal protection"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "200", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 24, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01977079", 
            "org_study_id": "CHD061-13"
        }, 
        "intervention": {
            "arm_group_label": [
                "Premature birth", 
                "Not premature birth"
            ], 
            "intervention_name": "procalcitonin", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "pregnancy", 
            "premature birth", 
            "procalcitonin"
        ], 
        "lastchanged_date": "December 5, 2013", 
        "location": {
            "contact": {
                "email": "lucie.auzanneau@chd-vendee.fr", 
                "last_name": "Lucie AUZANNEAU", 
                "phone_ext": "33"
            }, 
            "facility": {
                "address": {
                    "city": "La Roche sur Yon", 
                    "country": "France", 
                    "zip": "85925"
                }, 
                "name": "Centre hospitalier d\u00e9partemental Vend\u00e9e"
            }, 
            "investigator": {
                "last_name": "Guillaume DUCARME, PH", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "2", 
        "official_title": "Procalcitonin and Threatened Premature Delivery", 
        "overall_official": {
            "affiliation": "Centre hospitalier d\u00e9partemental Vend\u00e9e", 
            "last_name": "Guillaume DUCARME, PH", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France: The Commission nationale de l\u2019informatique et des libert\u00e9s", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Estimate serum procalcitonin according to premature or not in patients hospitalized for preterm labor.", 
            "measure": "procalcitonin rate", 
            "safety_issue": "No", 
            "time_frame": "up to 48 hours"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01977079"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Centre Hospitalier Departemental Vendee", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Centre Hospitalier Departemental Vendee", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "October 2013"
    }
}